HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.)
IL · US
Biopharmaceutical Development
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$60,000
Connections
3
Money connected to HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.)
These trails are from entities directly connected to HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) through ownership, employment, or organizational ties.
Covington & Burling LLP directed $49K to COVINGTON & BURLING LLP PAC across 2 contributions between June 2023 and December 2023.
AMGEN INC. PAC directed $3K to Veasey, Marc A.. Veasey, Marc A. voted YES on GENIUS Act, Guiding and Establishing National Innovation for U.S. Stablecoins (S.394) — which AMGEN INC. PAC advocates for.
AMGEN INC. PAC directed $2K to Carbajal, Salud O.. Carbajal, Salud O. voted YES on GENIUS Act, Guiding and Establishing National Innovation for U.S. Stablecoins (S.394) — which AMGEN INC. PAC advocates for.
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | Covington & Burling LLP | Hired COVINGTON & BURLING LLP to lobby on Pharmaceuticals | Source |
| Subsidiary of | AMGEN USA, INC. | Horizon Therapeutics was acquired by Amgen in 2023 | Source |
| Subsidiary of | AMGEN INC. PAC | Horizon Therapeutics was acquired by Amgen in 2023 | Source |